Triple Therapy: The Debate Goes On

Recorded On: 05/12/2019


Back to Package

  • Register
    • Non-member - $30
    • Member - $20
    • Resident/Fellow - $10
    • Student - $10

In this course the speaker will discuss the indications for anti-coagulation and anti-platelet therapy in patients with atrial fibrillation and coronary artery disease; review dual versus triple therapy in patients; undergoing percutaneous coronary intervention (PCI); review the previous and ongoing clinical trial results in patient on triple versus dual therapy. This lecture was recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 12, 2019 in Baltimore, MD.

Chad Link, DO, FACOI

Assistant Clinical Professor

Michigan State University College of Osteopathic Medicine

Assistant Clinical Professor
Michigan State University College of Osteopathic Medicine

Cardiology Section Chairman
Sparrow TCI

Components visible upon registration.